KRISTINE KUCERA: Open Payments
NPI 1699970368 · MELISSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184,465 in 438 payments from 20 companies in 2025. Trend: 2023 $221,341 · 2024 $167,102 · 2025 $184,465
Speaker / faculty: $127,618Consulting: $22,071Travel & lodging: $18,512Food & beverage: $8,768Speaker / faculty: $7,398Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 86 | $41,389 |
| Janssen Biotech, Inc. | 61 | $37,702 |
| ABBVIE INC. | 69 | $36,913 |
| Galderma Laboratories, L.P. | 44 | $16,174 |
| Novartis Pharmaceuticals Corporation | 22 | $12,407 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 25 | $9,028 |
| Amgen Inc. | 22 | $8,579 |
| E.R. Squibb & Sons, L.L.C. | 14 | $7,283 |
| PFIZER INC. | 14 | $5,550 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $3,827 |
Products named: Bimzelx, TREMFYA, RINVOQ, NEMLUVIO, ILUMYA, COSENTYX, Sotyktu, CIBINQO.
Industry payments across TX — which companies pay providers there.
